Literature DB >> 20008160

The effects of smoking and smoking cessation on mortality from cardiovascular disease among Japanese: pooled analysis of three large-scale cohort studies in Japan.

Kaori Honjo1, Hiroyasu Iso, Shoichiro Tsugane, Akiko Tamakoshi, Hiroshi Satoh, Kazuo Tajima, Takaichiro Suzuki, Tomotaka Sobue.   

Abstract

OBJECTIVES: To estimate the gender-specific risk of mortality from cardiovascular disease according to smoking status and time since smoking cessation among former smokers in Japan.
DESIGN: Prospective study.
SETTING: 140,026 males and 156,810 females aged 40-79 years who participated in one of three cohort studies conducted in Japan between 1980 and 1990. OUTCOME: The gender-specific hazard ratios (HRs) for cardiovascular disease mortality were calculated after adjustment for age and cohort.
RESULTS: The age-adjusted and cohort-adjusted HRs for current smokers compared with lifelong non-smokers were 1.51 (95% CI 1.38 to 1.64) for total cardiovascular diseases, 2.19 (95% CI 1.79 to 2.67) for coronary heart disease and 1.24 (95% CI 1.10 to 1.41) for total stroke in males, and were 1.85 (95% CI 1.65 to 2.06), 2.84 (95% CI 2.24 to 3.60) and 1.70 (95% CI 1.44 to 2.01), respectively, in females. The age-adjusted and cohort-adjusted HRs for former smokers compared with current smokers according to the time period since smoking cessation decreased by approximately 5 years after smoking cessation and reached the same level as lifelong non-smokers approximately 10 years after smoking cessation among both males and females.
CONCLUSIONS: The present study confirmed the association between smoking and mortality from cardiovascular disease in both males and females. Smoking cessation is a crucial preventive measure against death from cardiovascular disease.

Entities:  

Mesh:

Year:  2009        PMID: 20008160     DOI: 10.1136/tc.2009.029751

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  28 in total

Review 1.  Do differences in risk factors explain the lower rates of coronary heart disease in Japanese versus U.S. women?

Authors:  Akira Sekikawa; Bradley J Willcox; Takeshi Usui; John Jeffrey Carr; Emma J M Barinas-Mitchell; Kamal H Masaki; Makoto Watanabe; Russell P Tracy; Marianne H Bertolet; Rhobert W Evans; Kunihiko Nishimura; Kim Sutton-Tyrrell; Lewis H Kuller; Yoshihiro Miyamoto
Journal:  J Womens Health (Larchmt)       Date:  2013-09-28       Impact factor: 2.681

2.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

3.  Impact of age at smoking initiation, dosage, and time since quitting on cardiovascular disease in african americans and whites: the atherosclerosis risk in communities study.

Authors:  Rachel R Huxley; Hiroshi Yatsuya; Pamela L Lutsey; Mark Woodward; Alvaro Alonso; Aaron R Folsom
Journal:  Am J Epidemiol       Date:  2012-03-06       Impact factor: 4.897

4.  Reduction in total and major cause-specific mortality from tobacco smoking cessation: a pooled analysis of 16 population-based cohort studies in Asia.

Authors:  Jae Jeong Yang; Danxia Yu; Xiao-Ou Shu; Wanqing Wen; Shafiur Rahman; Sarah Abe; Eiko Saito; Prakash C Gupta; Jiang He; Shoichiro Tsugane; Yu-Tang Gao; Jian-Min Yuan; Woon-Puay Koh; Atsuko Sadakane; Yasutake Tomata; Ichiro Tsuji; Yumi Sugawara; Keitaro Matsuo; Yoon-Ok Ahn; Sue K Park; Yu Chen; Manami Inoue; Daehee Kang; Wei Zheng
Journal:  Int J Epidemiol       Date:  2021-02-05       Impact factor: 7.196

5.  Influence of cigarette smoking on coronary artery and aortic calcium among random samples from populations of middle-aged Japanese and Korean men.

Authors:  Nobutaka Hirooka; Takashi Kadowaki; Akira Sekikawa; Hirotsugu Ueshima; Jina Choo; Katsuyuki Miura; Tomonori Okamura; Akira Fujiyoshi; Sayaka Kadowaki; Aya Kadota; Yasuyuki Nakamura; Hiroshi Maegawa; Atsunori Kashiwagi; Kamal Masaki; Kim Sutton-Tyrrell; Lewis H Kuller; J David Curb; Chol Shin
Journal:  J Epidemiol Community Health       Date:  2012-07-29       Impact factor: 3.710

Review 6.  Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review.

Authors:  Winifred Ekezie; Rachael L Murray; Sanjay Agrawal; Ilze Bogdanovica; John Britton; Jo Leonardi-Bee
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

7.  Age at quitting smoking as a predictor of risk of cardiovascular disease incidence independent of smoking status, time since quitting and pack-years.

Authors:  Haider R Mannan; Christopher E Stevenson; Anna Peeters; Helen L Walls; John J McNeil
Journal:  BMC Res Notes       Date:  2011-02-15

8.  Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment?

Authors:  Yoshihiro Kokubo
Journal:  EPMA J       Date:  2011-04-02       Impact factor: 6.543

9.  A Japanese health success story: trends in cardiovascular diseases, their risk factors, and the contribution of public health and personalized approaches.

Authors:  Hiroyasu Iso
Journal:  EPMA J       Date:  2011-03-24       Impact factor: 6.543

10.  The impact of cigarette smoking on 24-hour blood pressure, inflammatory and hemostatic activity, and cardiovascular risk in Japanese hypertensive patients.

Authors:  Yuichirou Yano; Satoshi Hoshide; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-12-14       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.